18 February 2014 - Deborah Wilkes
Archived
Galpharm Healthcare is seeking to switch 250mg naproxen tablets for period pain from pharmacy to general-sales-list (P-to-GSL) status in the UK.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.